Genomic Profile of MYCN Non-Amplified Neuroblastoma and Potential for Immunotherapeutic Strategies in Neuroblastoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koo, H. H. | - |
dc.contributor.author | Lee, E. | - |
dc.contributor.author | Lee, J. W. | - |
dc.contributor.author | Lee, B. | - |
dc.contributor.author | Park, K. | - |
dc.contributor.author | Shim, J. | - |
dc.contributor.author | Sung, K. W. | - |
dc.contributor.author | Yoo, K. H. | - |
dc.contributor.author | Lee, Y. -H. | - |
dc.contributor.author | Park, W. -Y. | - |
dc.date.accessioned | 2021-09-27T06:15:18Z | - |
dc.date.available | 2021-09-27T06:15:18Z | - |
dc.date.created | 2021-09-14 | - |
dc.date.issued | 2020-12 | - |
dc.identifier.issn | 1545-5009 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/133021 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.title | Genomic Profile of MYCN Non-Amplified Neuroblastoma and Potential for Immunotherapeutic Strategies in Neuroblastoma | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | Lee, Y. -H. | - |
dc.identifier.wosid | 000581769200259 | - |
dc.identifier.bibliographicCitation | PEDIATRIC BLOOD & CANCER, pp.S124 - S125 | - |
dc.relation.isPartOf | PEDIATRIC BLOOD & CANCER | - |
dc.relation.isPartOf | PEDIATRIC BLOOD & CANCER | - |
dc.citation.title | PEDIATRIC BLOOD & CANCER | - |
dc.citation.startPage | S124 | - |
dc.citation.endPage | S125 | - |
dc.citation.conferencePlace | US | - |
dc.citation.conferenceDate | 2020-12 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.